View in EDS HTML Full Text PDF Full Text

Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial.

Saved in:
Bibliographic Details
Title: Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial.
Authors: Karaa, Amel1 (AUTHOR) AKARAA@mgh.harvard.edu, Bertini, Enrico2 (AUTHOR), Carelli, Valerio3,4 (AUTHOR), Cohen, Bruce5 (AUTHOR), Ennes, Gregory M.6 (AUTHOR), Falk, Marni J.7 (AUTHOR), Goldstein, Amy7 (AUTHOR), Gorman, Gráinne8 (AUTHOR), Haas, Richard9 (AUTHOR), Hirano, Michio10 (AUTHOR), Klopstock, Thomas11,12,13 (AUTHOR), Koenig, Mary Kay14 (AUTHOR), Kornblum, Cornelia15 (AUTHOR), Lamperti, Costanza16 (AUTHOR), Lehman, Anna17 (AUTHOR), Longo, Nicola18 (AUTHOR), Molnar, Maria Judit19 (AUTHOR), Parikh, Sumit20 (AUTHOR), Phan, Han21 (AUTHOR), Pitceathly, Robert D. S.22,23 (AUTHOR)
Source: Orphanet Journal of Rare Diseases. 11/21/2024, Vol. 19 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17501172
DOI:10.1186/s13023-024-03421-5